Received for publication March 21, 1963 BACTERIOLOGISTS have long used assays based on a dilution series to estimate the number of organisms in water (see for example, Cruickshank, 1960) . The same principle has recently been applied to the assay of cells in certain mammalian tumours (Hewitt, 1958; Silini and Hornsey, 1961; Berry and Andrews, 1961) . Serial dilutions of a suspension of tumour cells are injected into groups of animals, and the development of a tumour in a recipient animal implies that the inoculum contained at least one reproductively intact cell. Recipient animals for such assays are more expensive than the tubes of nutrient broth used by bacteriologists, and the supply of highly-inbred animals is usually the limiting factor on the amount of experimentation possible: hence it is reasonable to enquire how the best use may be made of a limited number of assay animals. An inefficient statistical method will of course waste information, and this is discussed in Appendix A.
METHODS
In this discussion the term " dose " is reserved for the number of morphologically typical tumour cells injected into a recipient animal. A reproductively intact cell is one that is capable of forming a tumour in the recipient. If a wellstirred suspension of cells is used and there is no clumping, the number of reproductively intact cells will follow a Poisson distribution (as pointed out by Hewitt, 1958) : that is, the chance of no tumour developing is e-x, where x is the mean number of intact cells per " dose ". For example: if a dose containing on average 3 morphologically typical tumour cells were given to each of 100 animals, and if 37 of these failed to develop tumours, then the mean number of reproductively intact cells per " dose " would be estimated as the solution of e-x = 0-37: in this case x -1. This would imply that about one in three of the morphologically typical tumour cells used were in fact reproductively intact.
An experimental assay will normally use several different " doses ", each injected into a group of assay animals: the problem becomes that of combining the information from all the groups, into one estimate of the proportion of tumour cells that are reproductively intact. Finney (1952) has discussed the maximum likelihood solution of this problem, using the ingenious device of an equivalent deviate. He points out that if an estimate is sought of the logarithm of the number of intact cells per "dose ", the analysis is simplified,* and the distribution of errors becomes more nearly normal. This manoeuvre is also convenient for studies of radiation and drug toxicity, where interest centres on the logarithm of a surviving fraction (i.e. on the logarithm of the intact proportion after treatment, minus the logarithm of the intact proportion of untreated control cells).
A computational method will be presented here for the maximum likelihood analysis of this type of assay. It is a modification of Finney's method (see note to Appendix B, Table II) ; and the logical and mathematical justification will be found in Finney's masterly treatise (1952) . An iterative process is necessary: from an initial estimate of the logarithm of the proportion of intact cells we obtain a better second estimate; this second estimate may be used to form an even better third estimate, and so on until the successive estimates differ negligibly, and the solution has been closely approached. In practice a judicious first estimate will often lead, after only one iterative cycle, to an adequate approximation; more than two cycles will only be needed if the first choice proves illjudged, or if the data are very irregular.
The calculations
For each " dose "we tabulate: (i) The " dose" in morphologically typical cells per assay animal.
(ii) n: the number of animals given this " dose ". (iii) r: the number of animals responding (i.e. developing tumours). (iv) q r/n: the proportion of animals responding at this " dose ". (v) Y: the initial estimate of log (number of intact cells per " dose "). A method of forming the initial estimates for the Y column will be discussed later, but it will be obvious that once Y is established for any one " dose ", all the remaining Y's will be fixed by the relationship between the various " doses ". Thus, if for a " dose " of 10 morphologically typical cells the initial estimate of Y were 0-0, then for a " dose " of 40 cells the initial estimate of Y would have to be +0-6 (adding the difference between log 40 and log 10).
Two further columns are tabulated for the first cycle: (vi) nw: the weight. This is the product of n (from column (i)), and w which depends only on Y, and is tabulated against Y in Appendix B, Table II . (vii) 0 : the correction deviate. This measures the extent to which the data for each "dose" disagree with the theory about the number of intact cells per "dose'" expressed by the Y column. Consequently it depends both on Y and on q, and may be found from the relationship:
* If the proportion of cells which are reproductively intact is E, and a " dose " of z morphologically typical cells is given, the chance of no tumour developing is P = e-E:, from the Poisson distribution. An estimate of P is given by p, the observed proportion of tumour-free animals. Now taking natural logarithms twice, we may define Y as:
Y log (-log P) so that:
Y -log E + log z aind we may also define y as log (-log p). The advantage of this transformation is that it makes the relationship linear in log z. We could proceed by fitting a straight line of unit slope to the y's, plotted against log z, but because the slope of this line is fixed the calculation can be rearranged so that only a weighted mean need be evaluated. If we wish for the maximum likelihood solution (which is known to give, in a certain sense, the most efficient estimate) an iterative process is needed, such as the process to be described in the text.
The quantities 5b and A are tabulated against Y in Appendix B, Table II, which also gives 51, the value assumed by q when q = 1 (i.e. when all animals tested at this " dose " respond).
The first iterative cycle ends with the calculation of a weighted mean of the 0's, which may be expressed (following Finney's use of the symbol S to signify summation) as:
Snwo Snw
The sum of the weights, Snw, and the algebraic sum of products Snwq can be accumulated conveniently on a desk calculator, but a slide-rule will suffice for the formation of +.
This mean correction 4, is added to each of the Y's to give a new Y column, with which the next cycle can begin. When 4 becomes satisfactorily small, iteration can cease and two relationships now hold:
(1) The variance of + is given by 1/Snw, and this is hence also the variance of the final estimate of the logarithm of the proportion of morphologically typical cells that are reproductively intact. This estimate will be symbolised by log E.
(2) An inconsistency x2 can be rapidly calculated after a column has been formed of the squares of the individual 0 values. It is given by: x2 _SnWO2 (Snwo)2
x -nwq2 -nw_ and has degrees of freedom one less than the number of " doses ". If this x2 is significant, it is evidence of internal inconsistency in the assay: the formula is easier than calculation of expected numbers to compare with the observed ones.
An example of the calculations
The data shown in Table I were accumulated over several months: considera- tion of the separate results of the assays during this period showed no evidence of trend, and no more than the expected variability about the mean: hence it is legitimate to pool the results of all these assays. The first three columns are filled in from the experimental data. For such large groups of assay animals it is just worth while to calculate q, the proportion responding, to three decimal places: two places would more often be appropriate.
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The Y column must now be filled in. A poor choice of Y's from which to start will not influence the final answer, but will necessitate extra iterative cycles. In Appendix B, The variance of estimate of log E resulting from an assay such as we are coInsidering is given by the reciprocal of Snw, the sum of the weights. Clearly the best assay design will be that which gives the largest Snw for the fewest assay animals. From this point of view, each animal may be thought of as contributing ani amount (w) to the precision of the assay, and this amount depends on Y ; that is on the actual number of reproductively intact cells given to the animal. Inspectioni of Appendix B, Table II, shows that w is at its maximum when Y + 0 2: that is, when the mean number of intact cells per "' dose " is about l 6. and the response rate about 80 per cent.
The pooled control data analysed above will serve to illustrate this argument. We note that it is, in general, a well-designed assay, for no animals have been tested at " doses" with very low weighting coefficients. However, the group of 125 mice given a "dose " of one morphologically typical tumour cell per mouse contribute 179) to Snw; and only 54 mice tested at a "' dose " of 4 cells would have contributed the same amount. Even here, then, a slight change in the dlesign of the assay would have obtained the same precision with a savingf of 71 mice.
If completely reliable advance information were available on the result to be expected from an assay, the assay would naturally be designed with only one glroup of assay animals. Every available animal would then be given a " dose" that was expected to contain on average 1 6 reproductively intact cells, and if all went well each assay animal would contribute the maximum to Snw. This, of course, is not a practical design for an assay, since with such a design inaccuracies in the advance information can have a disastrous effect on the precision of the assay, and even on the possibility of forming an estimate of log E at all. For example, if the initial estimate were pessimistic by a factor of two, the " dose" given would contain on average 3-2 reproductively intact cells, and with a group of 20 aniimals there would be a 43 per cent risk that all animals would develop ttumours.
Thus two factors affect the design of a practical assay; the desirability of economy of assay animals, and the need for insurance against inaccurate advance iniformation. If the advance information is unreliable, a wide range of " doses " must be used to provide insurance; if the advance information is reliable, such nisurance is merely wasteful.
In radiobiological work the proportion of cells treated in the same way which i-etain their reproductive integrity is expected to remain constant from one experiment to the next. If this condition is not fulfilled, then either the experiment has miscarried, or else any information that can be gleaned from it is not radiobiological. If it may be assumed that repeated assays will measure the same reproductively intact proportioni, then the assays can be planined to give at each stage the appropriate amount of insurance. When two or more assays have been made of the proportion of reproductively intact cells among cells treated in the same way, the problem arises of combining the information from both assays. The two estimates could be formed, and a weighted mean obtained using the Snw's as weights, but a better procedure is to pool the actual data, as if they were obtained in a single assay. If now the inconsistency x2 is significantly large, this may mean that the component assays are incompatible, in which case the pooling would not be legitimate. The point can be investigated by analysing the component assays separately: if they are internally consistent (but incompatible) reasons should be sought for this. If, however, one or more of the component assays are themselves internally inconsistent, they may be rejected and an attempt made to pool the remainder.
SUMMARY AND CONCLUSIONS
The statistical analysis of assays in vivo of the proportion of reproductively intact cells contained in tumour cell suspensions is discussed, and a method of analysis presented. This method of analysis, slightly modified from the method of Finney (1952) , allows the internal consistency of the assay to be checked, and the standard error of the final estimate to be computed.
Applications to the design of such assays are made, distinguishing cases where advance information is unreliable, and the assay must allow for a wide range of possible outcomes, from cases where reliable advance information permits an assay design which will give higher precision from the minimum number of assay animals.
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The Reed-Mueiich method is a quick and simple one for the estimation of a 50 per cent effective dose, for use when a wide range of regularly spaced doses (extending from 0 per cent to 100 per cent effective) have been tested, each oIn the same number of assay animals. The numbers of animals responding to the different doses are summed from low dose to high; and the numbers failing to respond are summed from high to low. The 50 per cent effective dose is estimated from these sums, either as the dose for which the two sums are equal, or by interpolatioli. The argument is that an animal which responds to a low dose would certainly have responded had the dose been higher ; one which fails to respond to a high dose would not have responded had the dose been smaller.
An example of the method is given in Appendix A, Table I , and it will be seeni that the process of forming the sums involves the tacit assumptions that had a group of animals been given a higher " dose " than was actually tested, all wsould have succumbed, and that had a group been given a lower " dose ", all would have survived. An estimate of the TD50 is formed bv graphical interpolation, usinlg the ratios S(+) +S( ) iin this case it is 7500 cells.
Reed and Muench recommended interpolation in the logarithms of the doses, but in radiobiological work the custom has arisen of interpolating directly in the doses ". This is somewhat less satisfactory than Reed anid Muench's own procedure.
No way of assessing the precision of such a Reed-Muench estimate is known except for the case of an underlying logistic distribution, where Pizzi (1950) loge 2), whether Q is plotted against x or against the logarithm of x. Consequently the Reed-Muench method must introduce a bias into the estimate; but when the number of animals per group is small, and the range of " doses " wide. this inherent bias is negligible.
When, however, the range of " doses " is narrow (as in the example given) a serious bias canl arise from the use of the Reed-Muench method. This bias is small when the centre of the range of ' doses " used is near to the true 50 per cenit point; but if the centre of the assay is moved away from the true 50 per cent point, the bias increases rapidly. In the example givein, the bias entering in this way amounts to about 20 per cent.
If the Reed-Muench method of analysis is to be used, the design of the assav must be such as to avoid this serious source of bias. That is, the experimenter must plan his assay for a wide range of " doses ", so as to ensure as far as possible that the highest " dose " will produce 100 per cent responses, the lowest " dose " 0 per cent. This is, of course, quite contrary to the priniciples of economical assay design discussed above, for where advance information is available a more efficient assay design is possible. This conlpulsorv waste of assay animals is the major defect of the Reed-Muench method.
Appendix A, Table J The Oxford University Ferranti Mercury computer table, which it did in four minutes. was used to compute the Appendix B, Table II 
